EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Durveqtix (fidanacogene elaparvovec) to treat severe and moderately severe haemophilia B in adults…
We value your input and always appreciate feedback. Your suggestions and comments help us improve our services, ensuring that we consistently meet your needs and exceed your expectations.
![]() |
MO - FR 9:00 am - 5:00 pm |
![]() |
|
![]() |
|
![]() |
Czech Republic, |